We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PRTT market cap is 166.61M. The company's latest EPS is USD 0.4237 and P/E is 6.84.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 5.94M | 0 | 93.12M |
| Operating Income | -51k | -2k | 5.81M | 0 | 27.76M |
| Net Income | -61k | -2k | 5.81M | 0 | 24.34M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 0 | 141k | 20.02M | 500k | 344.46M |
| Total Liabilities | 196k | 64k | 14.13M | 0 | 114.47M |
| Total Equity | -196k | 77k | 5.89M | 500k | 229.98M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -36k | -134k | 6.77M | -215k | -84.76M |
| Investing | N/A | -141k | -19.8M | -359k | 46.06M |
| Financing | 16k | 275k | 13.1M | 500k | N/A |
| Market Cap | 166.61M |
| Price to Earnings Ratio | 6.84 |
| Price to Sales Ratio | 1.79 |
| Price to Cash Ratio | 138.76 |
| Price to Book Ratio | 0.72 |
| Dividend Yield | - |
| Shares Outstanding | 57.45M |
| Average Volume (1 week) | 13.89k |
| Average Volume (1 Month) | 12.78k |
| 52 Week Change | 241.18% |
| 52 Week High | 3.10 |
| 52 Week Low | 0.20 |
| Spread (Intraday) | 0.48 (16.33%) |
| Company Name | Protect Pharmaceutical Corporation (PK) |
| Address |
5223 stacey avenue las vegas, nevada 89108 |
| Website | https://www.protectpharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
